VANGUARD selected for Horizon 2020 funding

Our VANGUARD proposal to develop a new bioartificial pancreas to cure type 1 diabetes has been selected for funding by the European Commission. Under the call SC1-BHC-07-2019 Regenerative medicine: from […]